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1. Introduction
  A number of environmental contaminants, chemicals 
and drugs including antibiotics dramatically alter the 
structure and function of various tissues and produce 
multiple adverse effects in the liver, kidney, heart and 
intestine[1]. Aminoglycoside antibiotics are frequently used 
in the treatment of severe infections of the abdomen and 
urinary tract[2]. Gentamicin (GM) is still considered to be an 
important aminoglycoside antibiotic against life threatening 
bacterial infections. However, nephrotoxicity and ototoxicity 
remain major problems for its effective long term clinical 
use[3]. GM is known to cause a number of morphologic, 
metabolic and functional alterations in the kidney and the 
specificity of GM nephrotoxicity is apparently related to 
its accumulation in the renal proximal convoluted tubules 
leading to tubular necrosis[4].
  Solanum xanthocarpum (S. xanthocarpum) Schrad. & 
Wendl. (family: Solanaceae) commonly known as Yellow 
Berried Nightshade (syn: Kantakari), is a prickly diffuse 
bright green perennial herb, woody at the base, 2-3 m 
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Objective: To evaluate nephroprotective potential of Solanum xanthocarpum (S. xanthocarpum) 
fruit extract(SXE) against gentamicin (GM) induced nephrotoxicity and renal dysfunction. 
Methods: Twenty-four Wistar rats were divided into four groups (n=6). Control rats that received 
normal saline (i.p.) and 0.5% carboxymethyl cellulose (p.o.) per day for 8 d. Nephrotoxicity was 
induced in rats by intraperitoneal administration of GM (100 mg/kg/d for 8 d) and were treated 
with SXE (200 and 400 mg/kg/d (p.o.) for 8 d). Plasma and urine urea and creatinine, kidney 
weight, urine output, blood urea nitrogen, renal enzymatic and non-enzymatic antioxidants 
and lipid peroxidation was evaluated along with histopathological investigation in various 
experimental groupsof rats. Results: It was observed that the GM treatment induced significant 
elevation (P<0.001) in plasma and urine urea, creatinine, kidney weight, blood urea nitrogen, 
renal lipid peroxidation along with significant decrement (P<0.001) in urine output, renal 
enzymatic and non-enzymatic antioxidants. SXE 200 and 400 mg/kg treatment to GM treated 
rats recorded significant decrement (up to P<0.001) in plasma and urine urea and creatinine, 
renal lipid peroxidation along with significant increment (up to P<0.001) in renal enzymatic and 
non-enzymatic antioxidants. Histological observations of kidney tissues too correlated with the 
biochemical observations. Conclusions: These finding powerfully supports that S. xanthocarpum 
fruit extract acts in the kidney as a potent scavenger of free radicals to prevent the toxic 
effects of GM both in the biochemical and histopathological parameters and thus validates its 
ethnomedicinal use.
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height found throughout India, mostly in dry places as a 
weed on road sides and waste lands. The fruits are of 1.3 cm 
diameter berry, yellow or white with green veins, surrounded 
by enlarged calyx[5]. The fruits are known for several 
traditional medicine uses like anthelmintic, antipyretic, 
laxative, antiinflammatory, urinary bladder, antiasthmatic, 
aphrodisiac activities and enlargement of the liver[6]. The 
stem, flowers and fruits are prescribed for relief in burning 
sensation in the feet accompanied by vesicular eruptions[7]. 
  The fruits are reported to contain several steroidal 
a lka lo ids  l ike  so lanacarpine ,  so lanacarpid ine , 
solancarpine, solasonine, solamargine and other 
constituents like caffeic acid, coumarins like aesculetin 
and  aescu l in ,  s t e ro ids  ca rpes te ro l ,  d iosgen in , 
campes te ro l ,  daucos te ro l  and  t r i t e rpenes  l ike 
cycloartanol and cycloartenol were reported from the 
fruits[8]. The antispasmodic, cardiotonic, hypotensive, 
antianaphylactic, arbuda tumour[9], Anti-urolithiatic and 
natriuretic activities were also reported[10]. Solasodine 
is present in a number of Solanum species (Solanaceae) 
such as Solanum khasianum, Solanum xanthocarpum,
Solanum nigrum, Solanumgracile, Solanum laciniatum etc[11]. 
Lupeol, apigenin and solamergine exhibited Solasodine 
anticancer property[12], anti-nociceptive[13], antioxidant 
activities of the chloroform extract[14] and hypoglycaemic[15]. 
  The flavanoids quercitrin and apigenin glycosides are the 
major chemical constituents which are present in the fruits 
of S. xanthocarpum[16]. To the best of our knowledge there 
were no any scientific reports available in support of its 
traditional claim of nephroprotective potential. Therefore, 
present study was designed to demonstrate the effect of
S. xanthocarpum fruit extract (SXE) against gentamicin 
induced renal damage in experimental animals. 
2. Materials and methods
2.1. Chemicals
  Gentamicin (Nicholas, Mumbai, India) from the source 
indicated in parentheses. All the chemicals used were of 
analytical grade and procured from Sigma chemicals Co., 
USA and Qualigens fine chemicals, Mumbai, India.
2.2. Preparation of plant extract
  Fresh and matured fruits were collected from campus 
garden of National Botanical Research Institute, Lucknow, 
India in November 2010. The plant material was identified 
and authenticated and the voucher specimen number NAB-
79023 was deposited in the institutional herbarium. The 
freshly collected fruits (2 kg) of S. xanthocarpum were dried 
and powdered. The powdered plant material (900 g) was 
macerated with petroleum ether, the marc was exhaustively 
extracted with of 50% ethanol for three days. The extract 
was separated by filtraction and concentrated on rotavapour 
(Buchi, USA) and then dried in lyophilizer (Labconco, USA) 
under reduced pressure. The yield obtained was 198.40 g of 
solid residue (yield 22.04% w/w). The extract obtained was 
further subjected to pharmacological investigation.
2.3. Animals
  Wistar rats weighing (150-170 g) and swiss albino mice 
(25-30 g) of either sex were procured from CDRI, Lucknow. 
They were kept in departmental animal house in well cross 
ventilated room at (22依1) 曟 with light and dark cycles of
12 h for 1 week before and during the experiments. Animals 
were provided with standard rodent pellet diet (Amrut, India) 
and the food was withdrawn 18-24 h before the experiment 
though water was given ad libitum. All studies were 
performed in accordance with the guide for the care and use 
of laboratory animals, as adopted and promulgated by the 
Institutional Animal Care Committee, CPCSEA, India (Reg. 
No. 222/2000/CPCSEA).
2.4. Acute oral toxicity studies
  Acute toxicity study was performed according to OECD 
guidelines No. 423[17]. Swiss albino mice of either sex were 
divided into six groups with six animals each. SXE was 
administered orally as a single dose to mice at different dose 
levels of 250, 500, 1 000, 1 500 and 2 000 mg/kg b.w. Animals 
were observed periodically for the symptoms of toxicity and 
death within 24 h and then daily for 14 d.
2.5. Gentamicin induced nephrotoxicity in rats
  Twenty-four Wistar rats (150-170 g) were divided into 
4 groups of 6 animals each. Group A: control rats (CON) 
that received normal saline (i.p.) and 0.5% carboxymethyl 
cellulose (CMC) (p.o.) for 8 days. Group B: gentamicin-
treated rats (GM) that received 100 mg/kg GM (i.p.) and 
0.5% CMC (p.o.) for 8 d[18]. Group C: (GM+SXE 200) treated 
rats that received 100 mg/kg GM (i.p.) and 200 mg/kg SXE 
(p.o.) for 8 d. Group D: (GM+SXE 400) treated rats that 
received 100 mg/kg GM (i.p.) and 400 mg/kg SXE (p.o.) for
8 d. After collection of blood and urine animals were sacrificed 
by cervical dislocation under mild ether anaesthesia and 
kidneys were harvested, rinsed in saline and stored at -80 曟
till further biochemical analysis.
2.6. Plasma and urine markers of renal damage 
  Rats of each group were individually housed in metabolic 
cages for 24 h and urine was collected on the 8th day of 
the treatment. Blood samples were collected from these 
overnight fasted animals through retro-orbital plexus 
puncture in ethylene diamine tetra acetic acid coated vials 
and plasma was separated by cold centrifugation of vial at 
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3 000 rpm for 10 min. Urea and creatinine were assayed in 
plasma and urine using commercially available kits (Reckon 
Diagnostics Ltd., Mumbai, India) as per instruction of the 
manufacturer and blood urea nitrogen (BUN) concentration 
was also measured as an indicator of renal function[19].
2.7. Preparation of homogenate of renal tissue 
  
  After the completion of the experiment, the kidneys were 
excised, weighed and homogenized in chilled Tris buffer 
(10 mM, pH 7.4) at a concentration of 10% (w/v) (Potter-
Elvenhjem glass homogenizer). Homogenates were then 
centrifuged at 12 000 rpm for 20 min (4 曟) in a high speed 
and supernatant and sediment were used for further 
biochemical estimations.
2.8. Measurement of renal lipid peroxidation
  Measurement of malonaldehyde as an index for lipid 
peroxidation (LPO) was done using thiobarbituric acid assay 
as per Buege and Aust[20]. 
2.9. Measurement of renal antioxidants
  Superoxide dismutase (SOD) was assayed in tissue 
supernatant by the method of Kakkar et al[21] based on 
the inhibition of the formation of nicotinamide adenine 
dinucleotide-phenazine methosulfate-nitro blue tetrazolium 
formazan. Catalase (CAT) activity in tissue supernatant was 
measured spectrophotometrically at 240 nm by calculating 
the rate of degradation of hydrogen peroxide, the substrate of 
the enzyme[22]. Reduced glutathione (GSH) content in tissue 
supernatant was measured spectrophotometrically by using 
Ellman’s reagent (Dinitrothiobenzoic acid) as a colouring 
reagent, following the method described by Beutler et al[23]. 
Whereas, ascorbic acid (AA) content was assayed in tissue 
sediment by the method of Roe and Kuether[24] using 2-4 
dinitro phenyl hydrazine.
2.10. Histopathological examination
  Pieces of kidney from each group were fixed immediately in 
10% neutral formalin for a period of at least 24 h, dehydrated 
in graded (50%-100%) alcohol and embedded in paraffin, cut 
into 4-5 毺m thick sections and stained with hematoxylin-
eosin. The sections were evaluated for the pathological 
symptoms of nephrotoxicity.
2.11. Statistical analysis
  
  The values were represented as mean ± SEM. for six rats. 
Analysis of variance (ANOVA) test was followed by individual 
comparison by Newman-Keuls test using Prism Pad software 
(version 3.0) for the determination of level of significance. 
The values of P<0.05 was considered statistically significant.
3. Results
3.1. Acute toxicity studies
  SXE produces no mortality at 2 000 mg/kg. Therefore, one-
tenth of the maximum no mortality dose of extract were 
selected as therapeutic lowest dose (200 mg/kg) and just 
double of it as highest dose (400 mg/kg) respectively, in this 
study.
3.2. Effect of SXE on kidney weight 
  The effect various doses of SXE were studied on kidney 
wt. in GM intoxicated animals. Renal injury induced by 
GM caused significant increases the kidney wt. by 81.13% 
compared to control group. The percentage protection in 
kidney wt. of treated groups at 200 mg/kg as 15.62 (P<0.05) 
when compared to toxic group while maximum percentage 
protection in kidney wt. at the dose of 400 mg/kg i.e. 36.45 
(P<0.001). Table 1 shows that, GM treated rats’ registered 
significant (P<0.001) increment in kidney weight.
3.3. Effect of SXE on urine output
  The effect various doses of SXE were studied on urine 
outflow (Table 1) in GM intoxicated animals. GM caused 
significant decreases the urine outflow by 39.74% compared 
to control group. The percentage augmentation in urine 
outflow of treated groups at 200 mg/kg as 34.04 (P<0.05) 
when compared to toxic group while maximum percentage 
augmentation in urine outflow at the dose of 400 mg/kg i.e. 
57.44 (P<0.001). 
3.4. Effect of SXE on urea and creatinine in plasma and 
urine
  The effect various doses of SXE were studied on urea 
and creatinine in GM intoxicated animals. Renal injury 
induced by GM caused significant changed in renal marker 
in plasma as urea by 178.54%, Creatinine by 170.78% but 
in case of urea and creatinine in urine 93.2% and 195.82% 
respectively compared to control group. The percentage 
protection in renal  marker in plasma of treated groups at 
200 mg/kg as urea 18.81 (P<0.01) , creatinine 16.59 (P<0.05), 
while these markers in urine 12.83 (P<0.01) and 15.4 (P<0.05) 
respectively when compared to toxic group while maximum 
percentage protection in renal markers in plasma at the 
dose of 400 mg/kg as urea by 50.52% (P<0.001), Creatinine by 
45.22% (P<0.001) but in case of  urea and  Creatinine in urine 
41.57% (P<0.001) and 43.59% (P<0.001) respectively (Table 1).
3.5. Estimation of renal lipid peroxidation 
  The results in Table 2 showed clear significant percentage 
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change in the levels of LPO in GM intoxicated rats as 169.71 
(P<0.001) compared to control group. Treatment with SXE at 
the doses of 200 and 400 mg/kg significantly prevented this 
heave in levels and the percentage protection in LPO were 
16.97 (P< 0.01) and 42.07 (P<0.001) respectively.
3.6. Estimation of renal antioxidants
  The percentage changed of SOD, CAT, GSH and ascorbic 
acid (Table 2) in GM intoxicated group were as 55.65 
(P<0.001), 60.36 (P<0.001), 51.84 (P<0.001) and 31.28 
(P<0.001) respectively. The percentage protection in SOD 
as 41.01 (P<0.01), 88.63 (P<0.001), CAT 32.58 (P<0.05), 98.72 
(P<0.001) and GSH 37.51 (P<0.05), 81.12 (P<0.001) while in 
ascorbic acid 12.19 (P<0.05), 29.29 (P<0.001) at the doses 
levels 200 and 400 mg/kg, respectively. In different doses 
level of SXE, 400 mg/kg has shown maximum protection 
which was almost comparable to those of the normal control. 
3.7. Effect of SXE on serum blood urea nitrogen 
  The effect various doses of SXE were studied on serum blood 
urea nitrogen in GM intoxicated animals. Renal injury induced 
by GM caused significant changed BUN in plasma by 53.94% 
compared to control group. The percentage protection in blood 
urea nitrogen of treated groups at 200 mg/kg as 12.31 (P<0.05) 
when compared to toxic group while maximum percentage 
protection in blood urea nitrogen at the dose of 400 mg/kg as 
by 24.13 (P<0.001) respectively.
3.8. Histopathological observations
  The histological changes in kidneys and pathological 
manifestations are presented in Figure 1. The nephrotoxicity 
were confirmed by evaluating the pathological symptoms 
such degeneration, desquamation, necrosis in tubules, 
intertubular haemorrhage; hyaline casts in tubules, 
congestion and swelling in glomerulus. Treatment with the 
SXE extract 200 and 400 mg/kg body weight ameliorated the 
toxic manifestations in the kidney. The histopathological 
observations supported this conclusion.
Figure 1.Histological study of kidney tissue in control and 
experimental groups of rats.
(A) Normal morphological view of renal sections in control group. (B) 
Histopathological view of renal sections in GM treated group showed 
the degeneration, desquamation, necrosis in tubules, and swelling 
in glomerulus (indicated by arrows) as compared to control group. 
(C) Animal treated with SXE 200 mg/kg karyopicnosis (indicated 
by arrow) and slight tubular degenerative and necrotic changes (D) 
Animal treated with SXE 400 mg/kg showed regeneration in tubular 
epithelial cells. 
Table 1
Effect of SXE on kidney weight, urine output, plasma urea, plasma creatinine, urine urea and urine creatinine level against GM induced 
nephropathy in rats (n=6).
Groups
Kidney weight 
(mg/100 body weight)
Urine output
 (mL/h)
Plasma Urine
Urea (mg/dL) Creatinine (mg/dL) Urea (mg/dL) Creatinine (mg/dL)
CON  0.53 依 0.04  0.78 依 0.07   23.49 依1.20  0.89 依 0.14   61.23 依 2.01  11.26 依 1.20
GM   0.96 依 0.06*   0.47 依 0.02*     65.43 依 3.00*   2.41 依 0.11*  118.31 依 4.30*   33.31 依 1.60*
GM + SXE 200   0.81 依 0.05#   0.63 依 0.03#      53.12 依 2.80##   2.01 依 0.15
#  103.12 依 4.10##   28.18 依 1.50#
GM + SXE 400     0.61 依 0.05###     0.74 依 0.04###       32.37 依 2.20###     1.32 依 0.12###     69.12 依 2.90###       18.79 依 1.30###
Values are mean 暲 S.E.M. *P<0.001 when compared with respective control group CON. 
#P<0.05, ##P<0.01, ###P<0.001 when compared with 
group (GM).
Table 2
Effect of SXE on SOD (Units/mg protein), CAT (毺mol of H2O2 consumed/mg protein), GSH (毺g/mg protein), LPO (nmol of malonaldehyde 
formed/mg protein), AA (mg/g of tissue) and BUN (mg/dl)]level against GM induced nephropathy in rats (n=6).
Groups SOD CAT GSH LPO AA BUN
CON  14.68 依 0.90  41.66 依 2.90  102.2 依 6.20  13.87 依 0.80  1.79 依 0.05  15.72 依 0.60
GM     6.51 依 0.30*   16.51 依 1.60*   49.21 依 4.30*   37.41 依 1.30*   1.23 依 0.03*   24.21 依 0.90*
GM + SXE 200     9.18 依 0.40##   21.89 依 1.90#   67.67 依 4.00#   31.06 依 1.40##   1.38 依 0.04#   21.22 依 0.80#
GM + SXE 400    12.28 依 0.70###     32.81 依 2.10###     89.13 依 5.10###    21.67 依 1.20###     1.59 依 0.06###     18.36 依 0.70###
Values are mean 暲 SEM. *P<0.001 when compared with respective control group CON.  
#P<0.05, ##P<0.01, ###P<0.001 when compared with 
group (GM).
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4. Discussion
  Nephrotoxicity is an undesired side effect of chemotherapy 
in general. Most chemotherapy drugs targets pathways 
that are essential to dividing cells[25]. Several studies 
have now documented the importance of reactive oxygen 
metabolites in gentamicin induced renal damage[26]. 
Nephrotoxicity of the drugs is usually associated with their 
accumulation in renal cortex, dependent upon their affinity 
to kidneys and on kinetics of drug trapping process[27].The 
nephrotoxicity of aminoglycoside antibiotics, and specially 
that of the most commonly used compound, gentamicin, 
is well documented[28,29]. Several studies have reported 
that oxygen-free radicals are considered to be important 
mediators of GM-induced acute renal failure. 
  GM induced nephrotoxicity is characterized by elevated 
levels of urea and creatinine in plasma as well as urine, 
severe proximal tubular necrosis, renal failure[30] and weight 
of kidney were found to be significantly increased in rats 
treated with  only GM[31]. Similar pattern of changes were 
also observed in our study following GM treatment. SXE 
supplementation to GM treated rats recorded decrement 
in levels of urea and creatinine in plasma as well as urine. 
These observations indicate at an improved renal function 
in form of effective clearance of urea and creatinine. GM-
treated rats showed that there was a significant decrease in 
urine volume as compared to control. But after the treatment 
with SXE the urine volume was significantly increase as 
compared to GM group. In fact, 400 mg/kg SXE increased 
the urine volume to the level of the control. Decrement in 
activity levels of renal SOD, CAT and GSH following GM 
treatment are in accordance with previous report on GM 
induced suppression of endogenous enzymatic antioxidant 
machinery[32]. SXE treatment efficiently prevented GM 
induced decrease in activity levels of SOD, CAT and GSH. A 
relationship between nephrotoxicity and oxidative stress has 
been confirmed in many experimental models[33-35]. 
  The elevated level of MDA, a marker of lipid peroxidation, 
indicates increased free-radical generation in the GM-
induced nephrotoxicity[36]. GM-induced increment in MDA 
content of plasma was significantly prevented by SXE 
treatment in the present study. GM-induced increment in 
MDA content of plasma was significantly prevented by SXE 
treatment in the present study. Therefore, the significantly 
lower levels of MDA in the tissues of treated groups as 
compared with the GM group indicate attenuation of lipid 
peroxidation. This was probably due to less damage by 
oxygen-free radicals with SXE. The involvement of oxygen-
free radicals in tissue injuries is well established[37]. Also, 
GM+SXE (200 and 400) groups recorded significantly higher 
levels of AA as compared to GM group, thus indicating that 
SXE treatment prevents GM induced depletion in levels of 
renal non-enzymatic antioxidants. GM administration to 
control rats produced a typical pattern of nephrotoxicity 
which was manifested by marked increase in serum BUN[38]. 
SXE supplementation to GM treated rats recorded decrement 
in levels of blood urea nitrogen in plasma. 
  Histopathological results demonstrating structural changes 
in renal tissue of aminoglycoside antibiotics such as GM were 
reported by some researchers[39.40]. Histopathological view of 
renal sections in GM treated group showed the degeneration, 
desquamation and necrosis in tubules and swelling in 
glomerulus, as compared to control group. Glomerular and 
tubular epithelial changes were considerably mild in the 
groups treated with GM+SXE-200 and GM+SXE 400 i.e. 
animal treated with SXE 200 mg/kg showed karyopicnosis 
and mild tubular epithelial changes while in case of animal 
treated with SXE 400 mg/kg showed regeneration in tubular 
epithelial cells. We think that, morphological changes in 
kidneys were because of GM injection, but these changes 
tended to be considerably mild in GM plus SXE treatment. In 
summary, our data indicate that GM-induced nephrotoxicity 
might be related to oxidative damage. Co-administration 
of SXE lessened the negative effects of GM-induced 
nephrotoxicity possibly by inhibiting free radical mediated 
process. Further investigation of these promising protective 
effects of SXE against GM-induced renal injury may have 
a considerable impact on developing clinically feasible 
strategies to treat patients with renal failure.
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